Literature DB >> 7936833

Cerebrovascular responses to carbon dioxide as detected by near-infrared spectrophotometry: comparison of three different measures.

N C Brun1, G Greisen.   

Abstract

Near-infrared spectrophotometry can be used to measure cerebral concentrations of oxyhemoglobin and deoxyhemoglobin. This has been applied to developing methods for quantifying cerebral blood volume (CBV), which is relevant for the investigation of the pathogenesis of brain injury in newborn infants as well as older infants. This study investigates the internal consistency between measurements of CBV using two methods: the oxygen method, which is able to determine absolute values of CBV, and the total Hb method, which can detect changes in CBV only. Cerebral blood flow (CBF) was also measured. Fifteen premature infants were examined. Due to practical problems, in only eight of these was a minimum of two CBF and two CBV values obtained both before and after a change in arterial PCO2 of at least 0.5 kPa. A significant difference between the CBV-CO2 reactivity found by the two methods was demonstrated: 0.89 mL/100 g/kPa (95% confidence interval = 0.63-1.26) for the oxygen method and 0.22 mL/100 g/kPa (95% confidence interval = 0.08-0.36) for the total Hb method. This finding is substantiated by the absolute values of CBV [mean value = 3.7 mL/100 g (SD = 1.1)], CBF [mean value = 11.3 mL/100 g/min (SD = 5.9)], and CBF reactivity [59 +/- 9% (SEM)]. All the values correspond well with previous findings, although the CBV reactivity determined by the oxygen method has not been reported previously. The reason for the discrepancy between the two methods is unclear, but induced changes in the scattering properties of the brain would give rise to errors influencing the total Hb method rather than the oxygen method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936833     DOI: 10.1203/00006450-199407001-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Abnormal cerebral haemodynamics in perinatally asphyxiated neonates related to outcome.

Authors:  J H Meek; C E Elwell; D C McCormick; A D Edwards; J P Townsend; A L Stewart; J S Wyatt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

2.  Calibration of a prototype NIRS oximeter against two commercial devices on a blood-lipid phantom.

Authors:  Simon Hyttel-Sorensen; Stefan Kleiser; Martin Wolf; Gorm Greisen
Journal:  Biomed Opt Express       Date:  2013-08-14       Impact factor: 3.732

3.  Cerebral blood flow increases over the first three days of life in extremely preterm neonates.

Authors:  J H Meek; L Tyszczuk; C E Elwell; J S Wyatt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

4.  Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy.

Authors:  Athina Pappas; Seetha Shankaran; Abbot R Laptook; John C Langer; Rebecca Bara; Richard A Ehrenkranz; Ronald N Goldberg; Abhik Das; Rosemary D Higgins; Jon E Tyson; Michele C Walsh
Journal:  J Pediatr       Date:  2010-12-10       Impact factor: 4.406

5.  Cerebral haemodynamics in preterm infants after exposure to dexamethasone.

Authors:  A Pellicer; F Gayá; T A Stiris; J Quero; F Cabañas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

6.  Dedicated near-infrared oximeter to monitor oxygenation in the superior sagittal sinus in newborn infants: a research agenda.

Authors:  Gorm Greisen
Journal:  J Biomed Opt       Date:  2022-03       Impact factor: 3.170

7.  Study of the relationship between regional cerebral saturation and pCO2 changes during mechanical ventilation to evaluate modifications in cerebral perfusion in a newborn piglet model.

Authors:  F Silvera; T Gagliardi; P Vollono; C Fernández; A García-Bayce; A Berardi; M Badía; B Beltrán; T Cabral; P Abella; L Farías; L Vaamonde; M Martell; F Blasina
Journal:  Braz J Med Biol Res       Date:  2022-02-28       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.